244 related articles for article (PubMed ID: 28117929)
1. Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.
Wang Y; Cheng N; Luo J
J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28117929
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis.
Miao JT; Gao JH; Chen YQ; Chen H; Meng HY; Lou G
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189742
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.
Hu X; Jiang H; Jiang X
Cancer Biol Ther; 2017 May; 18(5):331-338. PubMed ID: 28402230
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of lncRNA ANRIL inhibits the development of cisplatin resistance by upregulating miR‑98 in lung cancer cells.
Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Oncol Rep; 2020 Sep; 44(3):1025-1036. PubMed ID: 32705261
[TBL] [Abstract][Full Text] [Related]
5. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.
Wang G; Wang S; Li C
Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway.
Liu F; Tai Y; Ma J
Cancer Biol Ther; 2018 Jun; 19(6):534-542. PubMed ID: 29565706
[TBL] [Abstract][Full Text] [Related]
7. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
Lin FJ; Lin XD; Xu LY; Zhu SQ
Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of lncRNA X Inactive Specific Transcript (XIST) Suppresses Cell Proliferation and Enhances Radiosensitivity by Upregulating mir-29c in Nasopharyngeal Carcinoma Cells.
Han Q; Li L; Liang H; Li Y; Xie J; Wang Z
Med Sci Monit; 2017 Oct; 23():4798-4807. PubMed ID: 28985197
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway.
Zhao B; Lu YL; Yang Y; Hu LB; Bai Y; Li RQ; Zhang GY; Li J; Bi CW; Yang LB; Hu C; Lei YH; Wang QL; Liu ZM
Cancer Biomark; 2018 Feb; 21(3):613-620. PubMed ID: 29278879
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA OIP5-AS1 Promotes the Disease Progression in Nasopharyngeal Carcinoma by Targeting miR-203.
Tang J; Fu C; Li Y; Chen S; Jiang X; Xu W; Xie H
Biomed Res Int; 2021; 2021():9850928. PubMed ID: 33628831
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
13. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells.
Zou ZW; Ma C; Medoro L; Chen L; Wang B; Gupta R; Liu T; Yang XZ; Chen TT; Wang RZ; Zhang WJ; Li PD
Oncotarget; 2016 Sep; 7(38):61741-61754. PubMed ID: 27557514
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression.
Yin X; Liao Y; Xiong W; Zhang Y; Zhou Y; Yang Y
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1049-1057. PubMed ID: 32173903
[TBL] [Abstract][Full Text] [Related]
15. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
16. CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.
Liu Z; Cheng C; Luo X; Xia Q; Zhang Y; Long X; Jiang Q; Fang W
BMC Cancer; 2016 Mar; 16():238. PubMed ID: 26993269
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of long non-coding RNA XIST suppresses nasopharyngeal carcinoma progression by activating miR-491-5p.
Cheng Q; Xu X; Jiang H; Xu L; Li Q
J Cell Biochem; 2018 May; 119(5):3936-3944. PubMed ID: 29219216
[TBL] [Abstract][Full Text] [Related]
18. ANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer.
Zhang Z; Feng L; Liu P; Duan W
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30279206
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-101-3p inhibits nasopharyngeal carcinoma cell proliferation and cisplatin resistance through ZIC5 down-regulation by targeting SOX2.
Li T; Zhang G; Li W; Xiao J; Zhou Z; Tan G; Ai J
Biol Chem; 2023 Sep; 404(10):961-975. PubMed ID: 36752150
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA-LET, which is repressed by EZH2, inhibits cell proliferation and induces apoptosis of nasopharyngeal carcinoma cell.
Sun Q; Liu H; Li L; Zhang S; Liu K; Liu Y; Yang C
Med Oncol; 2015 Sep; 32(9):226. PubMed ID: 26243049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
